Comparison of Safety and Tolerability of Deutetrabenazine (DTBZ) During Titration and Maintenance in Patients With Tardive Dyskinesia (TD)

被引:0
|
作者
Anderson, K. [1 ]
Fernandez, H. [1 ]
Barkay, H. [1 ]
Wilhelm, A. [1 ]
Chaijale, N. [1 ]
Send, A. [1 ]
Savola, J. M. [1 ]
Gordon, M. [1 ]
机构
[1] Georgetown Univ, Washington, DC 20057 USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
75
引用
收藏
页码:S30 / S31
页数:2
相关论文
共 50 条
  • [1] Addressing involuntary movements in tardive dyskinesia (aim-td): Efficacy, safety, and tolerability of fixed-dose deutetrabenazine for the treatment of tardive dyskinesia
    Anderson, K.
    Stamler, D.
    Davis, M.
    Factor, S.
    Hauser, R.
    Isojarvi, J.
    Jimenez-Shahed, J.
    Ondo, W.
    Fernandez, H.
    [J]. MOVEMENT DISORDERS, 2017, 32
  • [2] Addressing Involuntary Movements in Tardive Dyskinesia (AIM-TD): Efficacy, Safety, and Tolerability of Fixed-Dose Deutetrabenazine for the Treatment of Tardive Dyskinesia
    Anderson, K.
    Stamler, D.
    Davis, M.
    Factor, S.
    Hauser, R.
    Isojarvi, J.
    Jimenez-Shahed, J.
    Ondo, W.
    Fernandez, H.
    [J]. MOVEMENT DISORDERS, 2017, 32 (12) : E7 - E7
  • [3] Addressing Involuntary Movements in Tardive Dyskinesia (AIM-TD): Efficacy, Safety, and Tolerability of Fixed-Dose Deutetrabenazine for the Treatment of Moderate to Severe Tardive Dyskinesia (TD)
    Anderson, Karen E.
    Stamler, David
    Davis, Mat D.
    Factor, Stewart A.
    Hauser, Robert A.
    Isojarvi, Jouko
    Jimenez-Shahed, Joohi
    Ondo, William G.
    Fernandez, Hubert H.
    [J]. NEUROLOGY, 2017, 88
  • [4] Indirect treatment comparison of valbenazine and deutetrabenazine efficacy and safety in tardive dyskinesia
    Aggarwal, Saurabh
    Serbin, Michael
    Yonan, Chuck
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (13) : 1077 - 1088
  • [5] Predictors of persistence to deutetrabenazine among patients with tardive dyskinesia (TD) and Huntington's disease (HD)
    Claassen, D.
    Ayyagari, R.
    Garcia-Horton, V.
    Zhang, S.
    Leo, S.
    [J]. MOVEMENT DISORDERS, 2021, 36 : S30 - S31
  • [6] Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia
    Dorfman, Benjamin J.
    Jimenez-Shahed, Joohi
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2021, 21 (01) : 9 - 20
  • [7] Randomized controlled trial of deutetrabenazine for tardive dyskinesia The ARM-TD study
    Fernandez, Hubert H.
    Factor, Stewart A.
    Hauser, Robert A.
    Jimenez-Shahed, Joohi
    Ondo, William G.
    Jarskog, L. Fredrik
    Meltzer, Herbert Y.
    Woods, Scott W.
    Bega, Danny
    LeDoux, Mark S.
    Shprecher, David R.
    Davis, Charles
    Davis, Mat D.
    Stamler, David
    Anderson, Karen E.
    [J]. NEUROLOGY, 2017, 88 (21) : 2003 - 2010
  • [8] Long-term Safety and Efficacy of Deutetrabenazine in Younger and Older Patients With Tardive Dyskinesia
    Sajatovic, M.
    Wilhelm, A.
    Finkbeiner, S.
    Barkay, H.
    Chaijale, N.
    Gross, N.
    Gordon, M.
    [J]. MOVEMENT DISORDERS, 2020, 35 : S34 - S34
  • [9] Long-Term Safety and Efficacy of Deutetrabenazine in Younger and Older Patients With Tardive Dyskinesia
    Sajatovic, Martha
    Finkbeiner, Stacy
    Wilhelm, Amanda
    Barkay, Hadas
    Chaijale, Nayla
    Gross, Nicholas
    Gordon, Mark Forrest
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2022, 30 (03): : 360 - 371
  • [10] Long-term Safety and Efficacy of Deutetrabenazine in Younger and Older Patients With Tardive Dyskinesia
    Sajatovic, Martha
    Wilhelm, Amanda
    Finkbeiner, Stacy
    Barkay, Hadas
    Chaijale, Nayla
    Gross, Nicholas
    Gordon, Mark Forrest
    [J]. NEUROLOGY, 2020, 94 (15)